MyNicas use in Hemodialysis
MyNicas can provide nephrologists valuable guidance in improving the management of their patients’ blood pressure during hemodialysis by trending the patients cardiac output during treatment. MyNicas data allows the clinician the ability to determine if intra dialytic hypotension is due to low preload or due to vasodilatation.
Intradialytic Hypotension (IDH), which occur in approximately 25% of all sessions, is the most common complication during hemodialysis. MyNicas can help to better understand the hemodynamic of IDH.
In Skilled Nursing Facility Dialysis Units MyNicas Intervention can be used to reduce Hospital Re-admissions by providing objective non-invasive hemodynamic and fluid monitoring during dialysis treatment.
For additional information contact Tom Jordan at
Sleep Medicine Breathing disorders during sleep are common in CHF
In the US 3-4% of percent of women and 6% to 9% of men in the general population have Obstructive Sleep Apnea (OSA).
Recent studies presented by Genesis (AARC 2017) estimated that over 40% of Skilled Nursing Patients diagnosed with COPD actually had OSA.
The Cardiovascular effects of OSA have been known and documented for many years. Recent negative effects in the introduction of adaptive servo ventilation (ASV) proved disastrous in those patients who had CHF that was uncontrolled those patients with reduced LEVF function resulted in several deaths.
For additional information regarding Sleep Applications contact Select Therapeutics and Technologies (STAT) at
These patients could be managed prior to Sleep Testing by managing their CHF through the measurement of the LVEF using the Granov Goor Index (GGI) provided with MyNicas testing.
Optimum treatment of CHF is the first step in the management of Sleep Disorder Breathing (SDB) and integration of the MyNicas System can provide a gateway for Sleep Labs to be pro-active as they work with the Cardiovascular Physicians.